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Summary
The formation of blood vessels is a vital process in embryonic development and in normal physiology. Current vascular 
modelling is mainly based on animal biology leading to species-to-species variation when extrapolating the results 
to humans. Although there are a few human cell based vascular models available, these assays are insufficiently 
characterized in terms of culture conditions and developmental stage of vascular structures. Therefore, well characterized 
vascular models with human relevance are needed for basic research, embryotoxicity testing, development of therapeutic 
strategies and for tissue engineering.
We have previously shown that the in vitro vascular model based on co-culture of human adipose stromal cells (hASC) 
and human umbilical vein endothelial cells (HUVEC) is able to induce an extensive vascular-like network with high 
reproducibility. In this work we developed a defined serum-free vascular stimulation medium (VSM) and performed 
further characterization in terms of cell identity, maturation and structure to obtain a thoroughly characterized in vitro 
vascular model to replace or reduce corresponding animal experiments.
The results showed that the novel vascular stimulation medium induced an intact and evenly distributed vascular-like 
network with morphology of mature vessels. Electron microscopic analysis assured the three-dimensional microstructure 
of the network containing lumen. Additionally, elevated expression levels of the main human angiogenesis-related genes 
were detected.
In conclusion, with the newly defined medium the vascular model can be utilized as a characterized test system for 
chemical testing as well as in creating vascularized tissue models.
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1  Introduction#
The formation of the blood vessel network is a vital process in 
growth and organ development (Carmeliet and Jain, 2011; Car-
meliet, 2005). In the embryo, endothelial precursor cells form 
new vessels that differentiate into a primitive vascular network 
(vasculogenesis) (Carmeliet and Jain, 2011). Subsequent ves-
sel sprouting (angiogenesis) creates a network of arteries and 
veins as well as capillaries that facilitate the exchange of gases 
and metabolites (Carmeliet and Jain, 2011; Adams and Alitalo, 
2007). To reach this level of complex organization, the imma-
ture vascular network must mature at the level of the vessel wall 
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morphology and as a whole network. Morphological maturation 
involves recruitment of mural cells, deposition of extracellular 
matrix and organ-specific specialization of cells, such as inter-
endothelial junctions and surface receptors. Maturation of the 
network involves branching and expanding the network to meet 
local, tissue-specific demands (Jain, 2003).
Since the formation and maintenance of the vascular network 
is a complex process, problems related to its regulation are com-
mon (Ucuzian and Greisler, 2007). Inadequate vessel mainte-
nance or growth causes ischemia in myocardial infarction and 
neurodegenerative or obesity-associated disorders, whereas 
excessive vascular growth or abnormal remodeling promotes 
cancer, inflammatory disorders and eye diseases (Potente et 
al., 2011). Moreover, genetic studies have shown that perturb-
ing embryonic vascular development can have adverse conse-
quences from benign vascular malformation to embryolethality 
and congenital defects (Knudsen and Kleinstreuer, 2011).
Angiogenesis models are important tools for studying the 
mechanisms of angiogenesis and the therapeutic strategies to 
modulate neovascularization (Ucuzian and Greisler, 2007). Due 
to an increasing amount of compounds affecting the vascular 
system, accurate vasculogenesis and angiogenesis models are 
needed for chemical safety testing and for drug development 
(Sarkanen et al., 2011; Bishop et al., 1999). Currently, preclini-
cal animal models are dominantly used for angiogenesis testing 
although they are not considered optimal in efficacy or relevance 
to humans. The most commonly used in vivo angiogenesis as-
says include the chick chorioallantoic membrane (CAM) assay, 
Matrigel plug assay, zebrafish embryo system, corneal micropo-
cket assay, rat/mouse hind limb ischemia model and rat aortic ring 
assay (Norrby, 2006; Auerbach et al., 2003). Despite the advan-
tage of providing more information on complex cellular interac-
tions compared to in vitro models, animal models are burdened 
by several disadvantages, such as variability, animal-specificity 
and ethical concerns (Norrby, 2006). Human cell based models 
have the potential to be valuable tools in predicting effects in 
man. However, the human relevance of these in vitro models 
needs to be confirmed in terms of cell identity, physiological ar-
chitecture and functionality (Bale et al., 2014; Hartung, 2011). 
In addition, the developmental stage of the model system and a 
defined medium composition are critical, especially when toxi-
cological applications are considered. Serum-free medium with 
xeno-free and defined supplements is considered essential for in 
vitro models to decrease the variation between experiments due 
to unknown components in the medium, and further, unknown 
binding properties of these components (Shen et al., 2013; Brun-
ner et al., 2010; van der Valk et al., 2010). Currently, culture 
media are still commonly supplemented with serum, although 
it has a highly uncharacterized composition, including various 
cytokines and growth factors, as well as a lot-to-lot variability 
(Lindroos et al., 2011; Brunner et al., 2010). 
We and others have shown that adipose stromal cells and um-
bilical vein endothelial cells are capable of self-assembling into a 
dense, three-dimensional vascular-like network (Sarkanen et al., 
2012; Merfeld-Clauss et al., 2010; Verseijden et al., 2010). While 
adipose stromal cells secrete factors that induce endothelial cell 
(EC) sprouting and lumen formation (Rubina et al., 2009; Trak-
tuev et al., 2008; Rehman et al., 2004; Kilroy et al., 2007; Bishop 
et al., 1999), the supporting stromal cells also enhance vascular 
basement membrane and lumen formation (Merfeld-Clauss et 
al., 2010; Newman et al., 2013; Stratman et al., 2009). 
The aim of this study was to develop a defined medium and 
further characterize the in vitro vascular model developed by us, 
which is composed of human adipose stromal cells (hASC) and 
human umbilical vein endothelial cells (HUVEC) (Sarkanen et 
al., 2012). Our results showed that the new vascular stimula-
tion media (VSM) developed in this study produces an exten-
sive vascular-like network with mature properties and provides 
a valid alternative to commercial EGM-2 medium when com-
paring vascular-like network formation capacity. This vascular 
model has the potential to be used in the safety and efficacy 
assessment of angiogenic compounds. In addition, the vascular-
like network combined with target cells, such as cardiomyocytes 
(Vuorenpää et al., 2014), can be used as a tissue engineering 
platform to create vascularized tissue models. 
2  Materials and methods
This study conforms to the principles outlined in the Declaration 
of Helsinki. The human adipose tissue samples were obtained 
from surgical operations and human umbilical cords were re-
ceived from caesarean sections with individual written informed 
consent at Tampere University Hospital, Tampere, Finland. The 
use of hASC and HUVEC were approved by the Ethics Com-
mittee of the Pirkanmaa Hospital District, Tampere, Finland 
with permit numbers R03058 and R08028, respectively. 
Isolation and culture of human adipose stromal cells
hASC were isolated from human adipose tissue by using a me-
chanical and enzymatic procedure described previously (Sar-
kanen et al., 2012). Briefly, human adipose tissue specimens 
were mechanically cut into small pieces and enzymatically di-
gested with 0.15% collagenase I (Invitrogen, Paisley, Scotland, 
UK) in Dulbecco’s Modified Eagle’s Medium Nutrient Mixture 
F-12 (DMEM/F12, Gibco, Invitrogen, Carlsbad, CA, USA). 
hASC were cultured in DMEM/F12 supplemented with 10% 
human serum (HS, Lonza Group Ltd, Basel, Switzerland) and 
1% L-Glutamine (Gibco). The cells were tested for mycoplasma 
contamination (MycoAlert® Mycoplasma Detection Kit, Lonza 
Group Ltd) before experimental use. 
Isolation and culture of human umbilical vein endothelial cells
HUVEC were isolated from human umbilical cord veins using 
0.05% collagenase I as described previously (Sarkanen et al., 
2011). The cells were cultured in EGM™-2 Endothelial Cell 
Growth Medium-2 (EGM-2, Lonza Group Ltd). Before use the 
cells were tested for mycoplasma contamination (MycoAlert® 
Mycoplasma Detection Kit, Lonza).
Establishment of the co-culture forming the vascular-like 
network
Co-culture of hASC and HUVEC was established as described 
previously (Sarkanen et al., 2012). Briefly, hASC were seeded in 
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EGM-2 (Lonza) at 20,000 cells/cm2. After 1-3 h HUVEC were 
seeded on top of hASC at 4,000 cells/cm2. The hASC were used 
at passage 2 and HUVEC at passage 4 in the co-culture (passage 
number increased at seeding). The day after plating, the stimula-
tion media were applied to the co-culture (see Tab. 1): 1) EGM-2 
containing epidermal growth factor, vascular endothelial growth 
factor A (VEGF), fibroblast growth factor 2 (FGF-2), insulin-
like growth factor I (IGF-I), ascorbic acid (AA), heparin, hydro-
cortisone (HY), antibiotic mix: 30 µg/ml gentamicin and 15 ng/
ml amphotericin and 2% fetal bovine serum (FBS); 2) EGM-2/
HS, where 2% FBS was replaced with 2% HS; 3) serum free ba-
sal medium (SFM); 4) Vascular stimulation medium (VSM). 
In this first media comparison study, the AA, HY and heparin 
in VSM were taken from the EGM-2 kit and used according 
to the manufacturer’s protocol (concentrations of these are not 
publicly available). After that, concentrations of AA, heparin 
sodium salt from bovine intestinal mucosa (HE) and HY pur-
chased from Sigma were optimized for VSM. In the concentra-
tion optimization study the tested concentrations of AA were 0, 
50, 100, 200, 500, 1000 and 2000 µg/ml; of HY 0, 20, 200, 1000, 
and 2000 ng/ml and of HE 0, 50, 500, 10,000 and 50,000 ng/ml. 
The concentrations of 10 ng/ml VEGF and 1 ng/ml FGF-2, used 
for VSM, had been optimized in our previous study (Sarkanen 
et al., 2012). The co-cultures were grown for 6 days prior to 
immunocytochemistry or quantitative real-time PCR (qPCR) 
processing. Stimulation medium was changed once during the 
6 day culture. 
Quantitative real-time PCR 
Genes activated in co-culture of hASC and HUVEC in EGM-
2 medium versus co-culture in VSM were analyzed by qPCR. 
Total RNA was extracted at day 6 using the RNAeasy minikit 
(Qiagen) following the manufacturer’s protocol. A step to elimi-
nate genomic DNA contamination was included in the isolation 
and performed with RNase-free DNase set (Qiagen). Reverse 
transcription of total RNA to cDNA was performed using RT2 
First Strand Kit (Qiagen) following the manufacturer’s instruc-
tions. 
Human Angiogenesis RT2 Profiler™ PCR Array (Qiagen, Va-
lencia, California, USA) was used to profile the expression of 
84 key angiogenesis-related genes (the comprehensive list of 
genes included in the array can be found in http://www.sabio-
sciences.com). The array was performed according to the man-
ufacturer’s protocol using BioRad CFX96 Real Time System 
(BioRad Laboratories, USA). The array contained five house-
keeping genes and controls, including genomic DNA control, 
Reverse Transcription Control and Positive PCR controls. The 
co-culture of hASC and HUVEC grown in EGM-2 medium was 
used as a control. Three independent experiments with the array 
were performed using the same cells. 
Immunocytochemistry
To analyze the vascular-like network formation and different 
cell types present in hASC and HUVEC co-culture, immunocy-
tochemical staining was performed. In primary antibody stain-
ing, endothelial cell specific antibody for rabbit anti-human von 
Willebrand factor IgG (anti-VWF, 1:100, F3520, Sigma) with 
common pericytic marker α-human smooth muscle actin (mon-
oclonal anti-SMA clone 1A4, 1:200, M0851, DAKO), vascular 
smooth muscle cell marker smooth muscle myosin heavy chain 
(anti-SMMHC, clone hSM-V, 1:800, M7786, Sigma), contrac-
tile smooth muscle cell marker calponin (anti-calponin, clone 
hCP, 1:800, C2687, Sigma), pericytic and smooth muscle cell 
progenitor marker platelet derived growth factor receptor-β 
(anti-PDGFRβ, clone PDGFR-B2, 1:800, P7679, Sigma), vas-
cular endothelial cadherin (CD144,Clone 55-7H1, 1:50, 555661, 
BD Pharmingen), monoclonal occludin (clone 1G7, 1:300, 
WH0004950M1, Sigma) or basement membrane marker colla-
gen IV (anti-COLIV, clone COL-94, 1:500, C1926, Sigma), all 
anti-human and all produced in mouse, except vWf, were used. 
Co-culture was fixed with 70% ethanol at day 6. After fixa-
tion, the cells were permeabilized with 0.5% Triton-X100 (MP 
Biochemicals, Ohio, USA) and non-specific binding sites were 
blocked with 10% bovine serum albumin (BSA, Roche Diagnos-
tics Corporation, Indianapolis, USA). Primary antibody in 1% 
BSA was applied to the cells. Secondary antibodies used were 
polyclonal goat anti-rabbit IgG tetramethylrhodamine (TRITC, 
1:50, T6778 Sigma), anti-rabbit IgG A568 (1: 400, A11011, In-
vitrogen) and anti-mouse IgG fluorescein isothiocyanate (FITC, 
1:100, F4143, Sigma). After immunocytochemical staining the 
Tab. 1: Stimulation media tested in vascular model
Acronym Basal medium Serum Growth factors Supplementation
eGM-2 eBM-2 2% FBS VeGF, FGF-2, IGF-I,  hydrocortisone, ascorbic acid, heparin,  
   epidermal growth factor GA-1000
eGM-2/HS eBM-2 2% HS VeGF, FGF-2, IGF-I, hydrocortisone, ascorbic acid, heparin,  
   epidermal growth factor GA-1000
basal SFM DMeM/F12 –   ItS, BSA, NaP, l-glutamine, t3,
VSM DMeM/F12 – VeGF, FGF-2 ItS, BSA, NaP, l-glutamine, t3,  
    hydrocortisone, ascorbic acid,  
    heparin sodium salt
0.1% ItS (insulin-transferrin-sodium selenite media supplement), 1.28 mM l-glutamine, 1% BSA (bovine serum albumin),  
2.8 mM NaP (sodium pyruvate), 100 IU/ml P/0.1 mg/ml S, 0.1 nM t3 (3,3’,5-triiodo-l-thyronine sodium salt), HS (human serum),  
FBS (fetal bovine serum), VEGF (vascular endothelial growth factor A), FGF-2 (fibroblast growth factor 2), IGF-I (insulin-like growth  
factor I), GA-1000 (30 µg/ml gentamicin and 15 ng/ml amphotericin), VSM (vascular stimulation medium), SFM (serum free medium)
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vascular-like network was analyzed and photographed with 
Nikon Eclipse TS100 inverted fluorescence microscope (Nikon, 
Tokyo, Japan) and Nikon digital sight DS-U2 camera (Nikon). 
Images were further processed with NIS Elements (Nikon, To-
kyo, Japan) and Adobe Photoshop CS3-software (Adobe Sys-
tems Incorporated, San Jose, CA, United States). 
Flow cytometric surface marker expression analysis of  
HUVEC and hASC
hASC were cultured in hASC medium (passage 1) for 6-7 days 
and HUVEC were cultured in EGM-2 medium (passage 3) for 
3 days prior to surface marker expression analysis using a BD 
FACSCanto II flow cytometer (BD Biosciences, Erembodegem, 
Belgium). For the flow cytometry analysis cells were divided 
into 5 ml polystyrene round bottom FACS tubes (BD, New Jer-
sey, USA) at 250,000 cells per tube. The cells were washed once 
with warm staining buffer (1% BSA in PBS) and centrifuged 
at 131 x g for 5 min, after which they were stained either for 
surface markers or for intracellular markers. 
Fixation and permeabilization were only performed for stain-
ing of intracellular markers. The fixation was conducted by 
incubating the samples for 30 min in 2% paraformaldehyde 
in PBS at room temperature (RT). The cells were then centri-
fuged at 500 x g for 5 min. Permeabilization of the cells was 
performed by 10 min incubation in 0.1% Triton-X100 in PBS at 
RT after which the cells were centrifuged at 500 x g for 5 min 
and washed once or twice with staining buffer before addition 
of antibodies. 
The labelled mouse anti-human antibodies used were intra-
cellular vWf-A2-allophycocyanin IgG2b (APC, #IC27641A) 
and eNOS- phycoerythrin IgG1 (PE, #560103), and surface 
markers CD144-FITC IgG1 (#560411), CD73-Phycoerythrin-
Cyanine IgG1 (PE-CY7, #561258), CD309-PE IgG1 (#560872), 
CD68-FITC IgG2b (#562117), NG2-PE IgG1 (#FAB2585P), 
CD90-FITC IgG1 (#561969), CD105-V450 IgG1 (#561447), 
CD34-APC IgG1 (#561209), CD140b-PE IgG2a (#558821), 
CD31-V450 IgG1 (#561653), CD45-PE IgG1 (#560975), 
CD14-FITC IgG1 (#561712). Isotype controls mouse IgG2b-
APC (#IC0041A), Mouse IgG1-PE-CY7 (#557872), mouse 
IgG1-PE (#559320), mouse IgG1-FITC (#555748), mouse 
IgG2b-FITC (#556655), mouse IgG1-V450-(#642268), mouse 
IgG1-APC (#550854), mouse IgG2a-PE (#551438). All anti-
bodies and their corresponding isotype controls used in the flow 
cytometry analysis were purchased from BD except NG2, vWf 
and IgG2b-APC, which were purchased from R&D Systems. 
Labelled antibodies were added into cell suspension in cold 
staining buffer and incubated on ice for 30 min in the dark. After 
incubation the cells were washed once with staining buffer and 
twice with PBS. Surface marker stained cells were centrifuged 
at 200 x g for 5 min and intracellular marker stained cells were 
centrifuged for 5 min at 500 x g. 
Flow cytometry analysis was performed with cells suspended 
in ice cold PBS and 5,000 events were analyzed per sample. 
Compensation was done with compensation particles, i.e., BD™ 
CompBeads (BD) according to the manufacturer’s instructions. 
The results were analyzed with BD FACSDiva™ Software 
(BD). The positive expression was obtained by gating 98% of 
the events isotype control results and then inverting the gate to 
obtain a percentage of positively stained cells in the samples. 
The results were calculated as percentages with SD.
Electron microscopy
hASC and HUVEC co-culture was performed in 24-well UpCell 
plates (ThermoFisher) for transmission electron microscopy 
(TEM) and on glass cover slips coated with 0.1% gelatin for 
scanning electron microscopy (SEM). Co-culture was main-
tained for 6 days and washed twice with PBS prior to fixation. 
SEM specimens were fixed in 2% glutaraldehyde in 0.1 M 
phosphate buffer after which the SEM samples were dehydrat-
ed in alcohol and dried in Baltec critical point dryer (Baltec, 
CPD030, Balzers, Liechtenstein). A layer of platinum was sput-
tered onto the specimens with a sputter coater (Agar Scientific, 
Stansted, England). Specimens were examined in a Zeiss Ultra 
Plus scanning electron microscope, (Carl Zeiss MT – Nanotech-
nology System Division, Carl Zeiss NTS GmbH, Oberkochen, 
Germany) using 5 kV as an accelerating voltage.
TEM specimens were detached from the temperature sensi-
tive 24-well UpCell plate and transferred to fixative with 1% 
glutaraldehyde, 4% formaldehyde mixture in 0.1 M phosphate 
buffer for 10 min. The cell sheet was immersed in 2% agarose in 
distilled water and postfixed in 1% osmiumtetroxide, dehydrat-
ed in acetone and embedded in Epon LX 112 (Ladd Research 
Industries, Vermont, USA). Thin sections were cut with Leica 
Ultracut UCT ultramicrotome, stained in uranyl acetate and lead 
citrate and examined in a Philips CM100 transmission electron 
microscope. Images were captured by a Morada CCD camera 
(Olympus Soft Imaging Solutions GMBH, Munster Germany).
Quantitative analysis of vascular-like network formation
Vascular-like networks, i.e., vWf-positive tubule structures 
formed in different stimulation media, were imaged using Cell-
IQ (Chipman tech., Tampere, Finland) with 10x objective and 
5x5 grid. The quantitation of the area of the vascular-like net-
work was performed using ImageJ software (National institutes 
of health, NIH, Maryland, USA) for the image analysis. Im-
ages were first converted to 8-bit gray scale, then background 
was subtracted and finally the binary threshold function was 
adjusted to obtain the best contrast of the vascular-like network 
against the background. With these settings, the total area of 
vascular-like network was calculated as the total number of pix-
els in images with set threshold.
Statistical analysis
Statistical analyses were performed and graphs processed with 
GraphPad Prism 5.0 (GraphPad Software, Inc., San Diego, CA, 
USA). The results concerning vascular-like network forma-
tion were subjected to one-way ANOVA followed by Dunnett’s 
post-test when applicable. The results were reported as total 
area ± SD and differences were considered significant when 
p < 0.05*, p < 0.01** and p < 0.001***. 
PCR results were analyzed with the PCR Array Data Analy-
sis Web Portal (http://www.SABiosciences.com/pcrarraydataa-
nalysis.php). The following formula was used to calculate the 
relative amount of the transcripts of the co-culture of hASC and 
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CD144 and CD31 and macrophage/monocyte markers CD68 
and CD14 were very low (< 1.4%). 
HUVEC were shown to express endothelial marker CD31 
and a specialized vascular endothelial marker CD144 at a high 
level (> 70%). Angiogenic endothelial marker CD105 and cell 
surface enzyme CD73 were found in the HUVEC population 
(57-68%). Markers for macrophages/monocytes (CD68) and 
mural cells (NG2) were low (≤ 2%). 
3.2  VSM induced optimal vascular-like  
network formation
Of the different stimulation media (Tab. 1), VSM induced an 
optimal vascular-like network formation (Fig. 1). The imaging 
analysis showed morphological differences in the vascular-like 
network in VSM compared to EGM-2 medium. VSM produced 
a uniformly distributed vascular-like network with connected 
branches and fewer cell aggregates. Low serum (2%) and se-
HUVEC in the VSM compared to transcripts of the co-culture 
in EGM-2 medium: ΔΔCT = ΔCT (VSM) − ΔCT (EGM-2). A 
two-fold change compared to housekeeping gene GAPDH was 
considered significant. 
3  Results
3.1  Phenotypic characterization 
Phenotypic characterization of the cells used in the vascular 
model was performed by analyzing the surface and intracellular 
markers of hASC and HUVEC separately (Tab. 2). The mesen-
chymal stem cell markers CD73, CD90 and CD105 were highly 
expressed (> 64%) in hASC. Also, pericyte marker PDGFR-β 
(CD140b) was strongly expressed (> 52%) in the hASC popu-
lation. Hematopoietic marker CD34 was moderately expressed 
(< 40%), whereas the expression levels of endothelial markers 
Tab. 2: Phenotypic characterization of human adipose stromal cells (hASC p1) and human umbilical vein  
endothelial cells (HUVEC p3)  
The expression of surface and intracellular markers was analysed by flow cytometry (5000 events per sample).  
Results are shown as percentage of positive cells.
Cells Protein Antigen Positive cells % SD n
hASC vWf von Willebrand factor 7.5 4.3 11
 CD144 vascular endothelial cadherin 1.4 2.9 9
 eNOS endothelial nitric oxide synthase 0.7 1.1 8
 CD140b PDGF Receptor b 52.8 16.0 6
 CD45 leukocyte common antigen 16.4 14.9 6
 CD14 expressed on monocytes/macrophages 0.7 0.8 7
 CD68 expressed on macrophages and monocytes 1.1 1.4 8
 CD309 VeGF receptor 2 1.2 3.5 6
 CD31 platelet endothelial cell adhesion molecule 0.9 3.1 6
 NG2 chondroitin proteoglycan 31.8 29.1 8
 CD90 thy-1 82.9 15.5 10
 CD105 endoglin 64.1 27.1 7
 CD73 ecto-5'-nucleotidase 88.8 6.7 12
 CD34 sialomucin-like adhesion molecule 40.9 34.3 10
HUVEC vWf von Willebrand Factor 45.6 13.2 13
 CD144 vascular endothelial cadherin 70.6 14.7 17
 CD309 VeGF receptor2 31.4 17.0 10
 CD73 ecto-5'-nucleotidase 68.7 17.1 14
 CD68 expressed on macrophages and monocytes 1.9 10.1 11
 eNOS endothelial nitric oxide synthase 48.4 18.4 13
 CD105 endoglin 57.4 26.6 9
 CD34 sialomucin-like adhesion molecule 43.1 18.6 9
 CD31 platelet endothelial cell adhesion molecule 81.3 13.7 8
 CD140b PDGF Receptor b 7.2 8.7 8
 NG2 chondroitin proteoglycan 2.0 1.1 7
Huttala et al.
Altex 32(2), 2015130
HUVEC in EGM-2 medium (control) and in VSM. Moderate 
differences in the expression of angiogenesis-related genes were 
detected between EGM-2 and VSM. In VSM, nine genes were 
up-regulated (Angpt1, F3, FIGF, IGF-I, LEP, MDK, MMP2, 
MMP9, PGF) and nine (CCL11, CXCL9, FN1, IL6, IL8, SER-
PINE1, TGFB2, THBS2, TIMP1) were down-regulated in com-
parison to EGM-2 medium. Fold changes and statistical sig-
nificances of the up- and down-regulated angiogenesis-related 
genes are shown in Table 3. 
3.4  Maturation stage, extracellular matrix 
production and 3D properties of the vascular-like 
network formed in VSM
Immunocytochemical staining of the vascular-like network 
formed in VSM showed the presence of platelet derived growth 
factor receptor-β (PDGFRβ) positive cells (Fig. 3D). Also, 
smooth muscle actin (SMA), smooth muscle myosin heavy 
chain (SMMHC) and contractile smooth muscle calponin posi-
tive cells surrounded the tubule structures (Fig. 3A-C). CD144 
and occludin positive staining indicated the presence of adher-
ence junctions between endothelial cells (Fig. 3E-F).
rum-free medium enabled stable cell attachment and induced a 
dense, connected vascular-like network with intact tubule walls. 
Human serum was found to induce a denser and more connected 
vascular-like network than FBS (Fig. 1).
In the supplement optimization several different concentra-
tions of ascorbic acid, heparin sodium salt and hydrocortisone 
were tested and compared to vascular-like network formed 
in EGM-2 medium. An optimal vascular-like network for-
mation was obtained with the AA concentration 100 µg/ml 
(Fig. 2A), HE concentration 0-500 ng/ml (Fig. 2B) and HY 
concentration 0.2 µg/ml (Fig. 2C). The results showed that a 
vascular-like network was formed in the absence of HE sup-
plement with minor morphological differences. However, low 
concentrations of HE (50-500 ng/ml) increased the total area 
of the vascular-like network significantly compared to EGM-
2 medium (Fig. 2B). 
3.3  Expression of angiogenesis-related genes  
in VSM compared to EMG-2
Expression of 84 angiogenesis-related genes was analyzed 
from a vascular-like network formed in co-culture of hASC and 
Fig. 1: Morphology of vascular-like network in 
different stimulation media with different serum 
concentrations 
Vascular-like networks were stained against Col IV (FItC, 
green) and vWf (tRItC, red). Co-localization is shown in 
the merged image. Vascular-like network formed in (A) 
commercial eGM-2 medium with 2% FBS, (B) serum-free 
VSM, (C) eGM-2 with 2% HS and (D) basal SFM. Scale 
bars 100 µm in each figure. Col IV= collagen type IV, 
VWF= von Willebrand factor, VSM= vascular stimulation 
medium, FBS= fetal bovine serum, HS= human serum, 
SFM=basal serum free medium.
Fig. 2: Vascular-like network formation (area in pixels) in different 
concentrations of (A) ascorbic acid, (B) heparin sodium salt and  
(C) hydrocortisone in VSM
Vascular-like network formed in VSM supplemented with different 
concentrations of ascorbic acid, heparin sodium salt or hydrocortisone were 
compared to eGM-2 medium and differences presented as follows:  
p < 0.05*, p < 0.01** and p < 0.001***. An optimal vascular-like network 
formation was obtained with 100 µg/ml ascorbic acid and 0.2 µg/ml 
hydrocortisone. Heparin sodium salt could be used in concentrations 
0-500ng/ml. Results are depicted as total area with standard deviations,  
n = 5 in each supplement and concentration. 
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The phenotypic analysis of the building blocks of the vascular 
model, i.e., the hASC and HUVEC, was performed using flow 
cytometry. HUVEC showed a strong expression of CD105 (en-
doglin), suggesting an active rather than quiescent state of the 
cells (Bernabeu et al., 2009). Interestingly, a recent study report-
ed a minor role of endoglin in vasculogenesis whereas VEGF-
induced angiogenesis was severely impaired in an endoglin de-
ficient mouse embryonic stem cell model (Liu et al., 2014). The 
high expression of CD144 and CD31 supports the active status 
of HUVEC in the formation of intercellular junctions. The level 
of CD73, a 5'-ectonucleotidase that normally suppresses pro-
inflammatory responses in human endothelial cells (Grunewald 
and Ridley, 2010) was high in our HUVEC analysis. Pericyte 
markers NG2 and CD140b (PDGFRβ) were low, indicating the 
absence of mural cells in the HUVEC population. 
This study confirms the earlier results shown by us (Sarkanen 
et al., 2012) and others (Lindroos et al., 2010; Traktuev et al., 
2008) that the stromal-vascular fraction extracted from adipose 
tissue is heterogenic. hASC expressed mesenchymal stem cell 
markers CD90, CD105 and CD73 at high levels, showing the 
Electron microscopic analysis confirmed the microstructure 
of the tubules formed in VSM. Tubules were shown to have 
a lumen, basement membrane and junctions (Fig. 4A-C). The 
three dimensional structure of the vascular-like network and 
shape of the tubules can be seen in the close-up image Figure 
4D.
4  Discussion
Present chemical safety testing and non-clinical drug develop-
ment rely mainly on animal biology although relevant safety 
testing data should be of human origin. Further, in vitro test 
systems should be thoroughly characterized in their human rel-
evance and functionality. In this study, we developed a novel 
vascular stimulation medium (VSM) and further characterized 
the in vitro human vascular model developed by us (Sarkanen et 
al., 2012). This defined in vitro vascular model has the potential 
to be used for safety assessment of compounds and for tissue 
engineering applications.
Tab. 3: Fold changes and statistical significance of expression of angiogenesis-related genes in vascular-like network formed 
in VSM compared to EGM-2 medium
Genes Target Fold change 2^(- ΔΔCT) Statistical significance
Up-regulated genes    
ANGPT1 angiopoietin 1 2.964 *
F3 coagulation factor III 3.255 *
FIGF vascular endothelial growth factor D 3.043 ns
IGF-I insulin-like growth factor I 16.555 ns
LEP leptin 2.932 ns
MDK neurite growth-promoting factor 2 2.06 ns
MMP2 matrix metallopeptidase 2 2.011 *
MMP9 matrix metallopeptidase 9 3.919 *
PGF placental growth factor 2.319 *
ANGPT2 angiopoietin 2 1.769 **
Down-regulated genes   
CCL11 chemokine ligand 11 2.613 ns
CXCL9 chemokine ligand 9 2.197 ns
FN1 fibronectin 1 2.295 *
IL6 interleukin 6 2.331 ns
IL8 interleukin 8 2.546 ns
SERPINE1 serpin peptidase inhibitor 3.465 **
TGFB2 transforming growth factor beta 2 2.080 ns
THBS2 thrombospondin 2 2.085 **
TIMP1 tIMP metallopeptidase inhibitor 1 5.01 **
VEFG-A vascular endothelial growth factor A 1.804 ns
TGFβ1 transforming growth factor beta 1 1.807 *
FGF-2 fibroblast growth factor 2 1.917 ns
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there is a moderate expression of CD34; these are markers for 
mesenchymal stem cells and endothelial progenitors. A hASC 
population of CD90+/CD34+ cells was shown to be capable 
of differentiating into endothelial cells and form capillary-like 
structures (De Francesco et al., 2009). 
The expression of mature endothelial cell markers CD31 and 
CD144 in the hASC population was very low. Interestingly, 
there is a report suggesting that adipose stromal cells may en-
hance endothelial differentiation of progenitor cells (Rubina et 
al., 2009). However, another essential marker for endothelial 
progenitor cells, CD309 (VEGFR2) (Yoder, 2012), showed very 
low expression in the six hASC lines that were analyzed in this 
study. Therefore, the presence of an endothelial progenitor cell 
population in the stromal-vascular fraction needs to be studied 
further. 
Serum-free VSM was shown to produce a reproducible, ex-
tensive mature vascular-like network and provide a suitable al-
ternative to the commercial EGM-2 medium (previously used 
in the model, containing 2% FBS). Serum had a strong corre-
lation with vascular-like network formation. At higher serum 
(10%) concentrations the network was shorter with broken tu-
bule walls, and random detachment of the cell layer occurred 
(data not shown). In low- or serum free (0-2%) environment, 
presence of a cell population with multilineage differentiation 
potential. Pericyte markers CD140b (PDGFRβ) and NG2 were 
expressed at high to moderate level, supporting the finding that 
pericytes from the hASC population are lining the vascular-like 
network in our model. 
We also analyzed whether the population of endothelial pro-
genitor cells capable of vasculogenesis could be found in hASC 
as suggested by some earlier reports (Sarkanen et al., 2012; 
Miranville et al., 2004; Heydarkhan-Hagvall et al., 2008). The 
results showed that, in addition to the high expression of CD90, 
Fig. 3: Vascular-like network formed in serum-free VSM 
shows vascular maturation markers at day 6
α-vWf-staining is shown in red in all figures. (A) Calponin-,  
(B) SMA- and (C) SMM-positive cells surrounding the vascular-like 
network. (D) α-PDGFRβ stained pericytes are located along  
the tubules. (e) CD144- and (F) occludin-positive junctions can be 
found in the tubule structures. Scale bar 100 μm in each image. 
VSM= vascular stimulation medium, vWf = von Willebrand factor, 
SMA = smooth muscle actin, SMM = smooth muscle myosin  
heavy chain, PDGFRβ = platelet derived growth factor receptor β, 
CD144 = vascular endothelial cadherin.
Fig. 4: Transmission (A, B, C) and scanning (D) 
electron microscopy images of the vascular-like 
network cultured in VSM
(A) Mature tubule with lumen = L and extracellular matrix 
= ECM. The lumen is filled with debris from the apoptotic 
cells. Scale bar 2 µm. (B) Close-up image with basement 
membrane = BM, adherence junction = AJ and lumen of 
the vascular-like tubules. Scale bar 2 µm. (C) tubule in 
earlier stage of vascular development showing endothelial 
cell with large nucleus (white arrow), lumen, adherence 
junctions and eCM. Scale bar 2 µm. D) Scanning electron 
microscopy image shows the 3D structure and the tubule 
shape of the vascular-like network. Scale bar 2 µm.  
VSM = vascular stimulation medium. 
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cular-like network. However, it produced cell aggregates at 
high concentrations whereas a lack of hydrocortisone induced 
a sparse vascular-like network. Our results suggest that hydro-
cortisone acts as a mitogen in the vascular model. Other sup-
plements of the VSM included ITS (insulin, transferrin, selenic 
acid medium supplement), BSA, sodium pyruvate, L-glutamine 
and T3 (3,3',5-triiodo-L-thyronine). The concentrations of these 
supplements were reported earlier by us (Vuorenpää et al., 2014) 
and were used in this study with minor modifications. 
Lumen formation is critical for the transformation of cords in-
to a perfusable vascular system (Charpentier and Conlon, 2014). 
Electron microscopic analysis assured the formation of 3D vas-
cular microstructure including lumen in the novel VSM. Tubules 
at different stages of lumen development were detected, indicat-
ing the ongoing process of network formation at day 6. The ini-
tiation of lumen development is triggered by apical-basal polar-
ity of the endothelial cells in which CD144 plays a critical role 
in promoting the localization of polarity markers (Charpentier 
and Conlon, 2014). The electron microscopic analysis as well as 
immunocytochemistry results of this study showed that hASC 
and HUVEC co-culture actively produces extracellular matrix 
(ECM) components, including fibrillins, thus creating natural 
3D scaffold around them. The reciprocal interaction between 
ECM stroma and vascular network is important in directing ves-
sel growth (Hoying et al., 2014; Du et al., 2014). The hASC and 
HUVEC co-culture gives mechanical support for other target 
cells, e.g., cardiomyocytes, and, additionally, the microenviron-
ment formed by the co-culture enhances target cell viability as 
reported previously (Vuorenpää et al., 2014). This 3D vascular 
model provides a more in vivo-like test system without an artifi-
cial scaffold that may interfere with the cell-cell interactions or 
affect the toxicological applications of the model.
In the genotypic analysis 84 human angiogenesis-related 
genes were studied. Nine genes were down-regulated and nine 
genes up-regulated in VSM compared to EGM-2 medium. The 
expression of angiopoietin 1, a marker for mature tubules, was 
significantly higher in VSM compared to EGM-2 medium, 
whereas angiopoietin 2, a marker for the early stage, i.e., sprout-
ing angiogenesis, was slightly upregulated in VSM. VEGF-A and 
FGF-2, indicators of early stage angiogenesis, were moderately 
yet not significantly down-regulated in VSM compared to EGM-
2. Since both media included VEGF and FGF-2, the expression 
of these growth factors was apparently unnecessary for the 
cells. On the contrary, placental growth factor (PGF) showed 
modest up-regulation in VSM. PGF and its receptor VEGFR-1 
are minimally expressed in adult quiescent vasculature, but are 
markedly up-regulated during pathological conditions (Carme-
liet et al., 2001). TGFβ1, a marker for tubule maturation, was 
slightly down-regulated in VSM. Vessel maturation relies partly 
on TGF-β signaling and TGF-β stimulates mural cell prolif-
eration and migration and production of ECM (Potente et al., 
2011). The gene expression analysis confirms the finding that 
VSM enhances the maturation of the vascular-like network.  
Interestingly, the expression of insulin like growth factor 
(IGF-I) showed the highest up-regulation in VSM. IGF-I treat-
ment in myocardial infarction has been shown to increase cir-
culating angiogenic growth factors, thus providing protection 
network formation increased, tubules were highly branched and 
tubule walls remained intact. In serum-free conditions we de-
tected thinner and more branched tubules as also reported by 
Yang and Xiong (Yang and Xiong, 2012). Serum-free medium 
is ideal for use in drug development, since serum is a complex 
mixture of components with unknown composition and protein 
binding affinities (Shen et al., 2013). Furthermore, a tissue con-
struct aimed for clinical therapy should be cultured in human 
serum or, preferably, in a serum-free environment to avoid the 
risk of infection and severe immune reactions in the recipient 
(Patrikoski et al., 2013; Lindroos et al., 2011, 2010; Holm et 
al., 2010). 
Fetal bovine serum (FBS), although being the most widely 
used growth supplement, holds ambiguous, unknown effects for 
cell culture and also raises ethical concerns due to the number 
of bovine fetuses needed for serum production (Gottipamula 
et al., 2013; Brunner et al., 2010). In this study, microscopical 
analysis showed that HS was more inductive for vascular-like 
network formation than FBS. Replacement of FBS with HS has 
been reported to support equal or higher proliferation rates and 
differentiation capacity of adipose stromal cells (Lindroos et al., 
2011; Brunner et al., 2010). Furthermore, human mesenchymal 
stem cells have been shown to maintain their immunophenotype 
and multilineage potential in serum-free medium (Patrikoski et 
al., 2013; Mark et al., 2013).
In this study we developed a defined vascular stimulation 
medium since commercial media producing companies do not 
necessarily publish the specific composition of their media. 
This might complicate the use of commercial media in toxico-
logical studies as medium components may interact with test 
compounds. In addition to commonly used VEGF and FGF-2 
defined by us earlier (Sarkanen et al., 2011), we found that the 
network formation can be further improved by addition of AA, 
HE and HY. Ascorbic acid (vitamin C) is an essential nutrient for 
human endothelial cells necessary for their effective migration 
and for the synthesis of collagen type IV, an important compo-
nent of basement membrane (Telang et al., 2007). In this study, 
the formation of basement membrane around the tubules was 
impaired in the absence of AA (data not shown). However, AA 
inhibited angiogenesis at high concentrations (1000-2000 µg/
ml) as reported previously (Mikirova et al., 2008). Therefore, 
AA is essential for collagen IV formation in basement mem-
brane at low concentrations.
Although HE is needed for the attachment of some growth fac-
tors to their cell surface receptors (Ashikari-Hada et al., 2005) 
and was found to be beneficial for the network formation, it did 
not induce a significant advantage to the morphology or branch-
ing of the tubules. Since HE is an animal derived substance it 
should rather be avoided where clinical applications are con-
cerned. The lack of need for added HE can be explained by the 
secretion of perlecan by HUVEC (Murikipudi et al., 2013; Sch-
lessinger et al., 2000). Our results correlate with earlier studies 
(Khorana et al., 2003; Jung et al., 2001) showing that HE inhib-
its vascular-like network formation at high concentrations.
Hydrocortisone, although not pro-angiogenic itself, has a 
beneficial effect on angiogenesis (Goding, 2009). In this study, 
hydrocortisone increased the number of branches in the vas-
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against myocardial ischemia in rats (Mathews et al., 2011). In 
vitro IGF-I stimulates migration and tube-forming activity of 
endothelial cells (Shigematsu et al., 1999; Nakao-Hayashi et 
al., 1992). Also leptin, a hormone secreted by adipocytes, was 
found to be up-regulated. Leptin signaling acts as a link between 
adipocytes and the vasculature (Sierra-Honigmann et al., 1998). 
It also increases the production of VEGF and enhances the ex-
pression of MMP-2 and MMP-9 (matrix metallopeptidases) in 
HUVEC (Park et al., 2001). This was seen as an up-regulation 
of MMP-2 and MMP-9 enzymes that are involved in degrada-
tion of the ECM at the early stages of angiogenesis (Kasper et 
al., 2007; Cornelius et al., 1998). 
In vivo studies in mice have revealed that the adult quiescent 
vasculature becomes less dependent on VEGF for its mainte-
nance (Gerber et al., 1999). However, during pathological con-
ditions – such as ischemia, inflammation or malignancy – an-
giogenic endothelial cells are stimulated by increased VEGF 
levels (Carmeliet et al., 2001). The VEGF signaling pathways 
have been conclusively identified as central for the processes of 
vasculogenesis, angiogenesis and lymphangiogenesis. VEGF-
D induces sprouting lymphangiogenesis when overexpressed 
in transgenic mice and also in various tumor models (Lohela 
et al., 2009). The up-regulation of vascular endothelial growth 
factor D (FIGF) as a marker for lymphangiogenesis suggests 
the versatile modifications of our vascular model. In future ap-
plications, it may be possible to replace HUVEC with lymphatic 
endothelial cells to form a lymphangiogenesis model.
5  Conclusion
The vascular model characterized in this study forms a vascular-
like network with mature properties. The developed novel medi-
um provides a valid alternative to commercial EGM-2 medium 
and benefits the use of the model in toxicological studies as well 
as in efficacy studies in drug development. This characterized 
vascular model is currently under intra-laboratory validation 
that is performed according to OECD guidance document No. 
34 (OECD, 2005) to verify the reliability and human relevance 
of the test system with known reference chemicals. The vali-
dated vascular model will be used in toxicity testing and can be 
combined with other target cell types from different tissues to 
create complex, vascularized tissue models. 
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